Shuttle Pharmaceuticals Holdings (SHPH) Depreciation and Depletion (2021 - 2025)
Shuttle Pharmaceuticals Holdings' (SHPH) quarterly Depreciation and Depletion came in at $1008.0 in Q3 2025, up 27.11% year-on-year from $793.0 in Q3 2024, and up 202.96% quarter-over-quarter from -$979.0 in Q2 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Depreciation and Depletion (2021 - 2025) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Depreciation and Depletion history runs 5 years deep, the most recent figure standing at $1008.0 for Q3 2025.
- On a quarterly basis, Depreciation and Depletion rose 27.11% year-over-year to $1008.0 in Q3 2025; TTM through Sep 2025 was $2833.0, a 49.86% decrease from a year earlier, with the FY2024 full-year figure at $5463.0, down 19.79% from the prior year.
- Depreciation and Depletion rose to $1008.0 in Q3 2025 per SHPH's latest filing, from -$979.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $2168.0 in Q4 2021 and bottomed at -$979.0 in Q2 2025.
- The 5-year median for Depreciation and Depletion is $1485.0 (2022), against an average of $1340.7.
- Across the five-year window, Depreciation and Depletion surged 33.27% in 2023 and tumbled 201.77% in 2025, its largest moves.
- Year by year, Depreciation and Depletion stood at $2168.0 in 2021, then sank by 31.37% to $1488.0 in 2022, then jumped by 33.27% to $1983.0 in 2023, then fell by 9.43% to $1796.0 in 2024, then plunged by 43.88% to $1008.0 in 2025.
- Per Business Quant, the three latest SHPH Depreciation and Depletion figures stand at $1008.0 (Q3 2025), -$979.0 (Q2 2025), and $1008.0 (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 36.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 21.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 7.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 28.00 Mn |
| 10 | Shuttle Pharmaceuticals Holdings | 120,186.04 | 120,186.04 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1,008.00 |
| Sep 30, 2025 | 1,008.00 |
| Jun 30, 2025 | -979.00 |
| Jun 30, 2025 | -979.00 |
| Mar 31, 2025 | 1,008.00 |
| Mar 31, 2025 | 1,008.00 |
| Dec 31, 2024 | 1,796.00 |
| Dec 31, 2024 | 1,796.00 |
| Sep 30, 2024 | 793.00 |
| Sep 30, 2024 | 793.00 |
| Jun 30, 2024 | 962.00 |
| Jun 30, 2024 | 962.00 |
| Mar 31, 2024 | 1,912.00 |
| Mar 31, 2024 | 1,912.00 |
| Dec 31, 2023 | 1,983.00 |
| Dec 31, 2023 | 1,983.00 |
| Sep 30, 2023 | 1,858.00 |
| Sep 30, 2023 | 1,858.00 |
| Jun 30, 2023 | 1,482.00 |
| Jun 30, 2023 | 1,482.00 |